Sum Lam
Overview
Explore the profile of Sum Lam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lam S, Lee C, Fong C, Wong Y, Shiu S, Mak L, et al.
J Clin Endocrinol Metab
. 2023 Nov;
109(3):e1048-e1054.
PMID: 37933700
Background And Aims: Tsukushi (TSK) is a recently identified hepatokine, and we aimed to investigate the association between systemic TSK and the severity of nonalcoholic fatty liver disease (NAFLD) in...
2.
Lam S, Lui D, Shiu S, Wong Y, Tan K
J Lipid Res
. 2023 Apr;
64(6):100380.
PMID: 37094639
The inducible degrader of LDL receptor (IDOL) acts as a post-transcriptional degrader of the LDL receptor (LDLR). IDOL is functionally active in the liver and in peripheral tissues. We have...
3.
Lam S, Shiu S, Wong Y, Choon-Beng Tan K
J Diabetes
. 2022 Jun;
14(6):394-400.
PMID: 35705192
Background: As a type 1 transmembrane protein, a disintegrin and metalloprotease 10 (ADAM10) is responsible for the cleavage of a variety of cell surface molecules and has been implicated in...
4.
Pinkhasov A, Collantes C, Chen M, Fazzari M, Coriolan S, Lam S
J Pharm Pract
. 2021 Jun;
34(5):675-677.
PMID: 34159827
No abstract available.
5.
Chan M, Dimitriou A, Lam S
Cardiol Rev
. 2020 Sep;
29(2):100-108.
PMID: 32897887
Diabetes mellitus (DM) is a complex and chronic condition that requires continuous medical care. Uncontrolled hyperglycemia can lead to serious microvascular and macrovascular complications, such as coronary artery disease, peripheral...
6.
Gu A, Farzadeh S, Chang Y, Kwong A, Lam S
Clin Med Insights Cardiol
. 2019 Apr;
13:1179546819839418.
PMID: 31019371
Background: Diabetes and hypertension are the 2 leading risk factors for suboptimal cardiovascular and renal outcomes. These 2 conditions often coexist and can benefit from antihypertensive therapy, which may lead...
7.
Lee K, Cham S, Lam S
Cardiol Rev
. 2018 Aug;
26(6):331-338.
PMID: 30067518
Venous thromboembolism (VTE) is a common and preventable cause of morbidity and mortality in hospitalized patients. Low-molecular-weight heparin, low-dose unfractionated heparin, fondaparinux, and warfarin have been the mainstay options for...
8.
Lam S, Macina L
Consult Pharm
. 2017 Oct;
32(10):610-622.
PMID: 28992822
Objective: To offer an update on insomnia in older adults and treatment options. Data Sources: A search of PubMed using the terms "insomnia" and "older adults" was performed. Current guidelines,...
9.
Pinkhasov A, James S, Fazzari M, Singh D, Lam S
Clin Drug Investig
. 2017 Sep;
37(12):1137-1141.
PMID: 28933013
Background And Objective: Abnormalities in melatonin levels have been linked to delirium. This dysregulation may be offset with the use of ramelteon, a melatonin receptor agonist. The purpose of this...
10.
Mondiello T, Lam S
Consult Pharm
. 2015 May;
30(5):283-6.
PMID: 25979127
The recently announced discontinuation of Namenda (memantine HCl) and consequent shortage of Namenda XR (memantine HCl extended-release) is a matter that affects physicians, patients with Alzheimer's disease, caregivers, and consultant...